Advancing investigational pre-clinical research of APL-9099 3, a potential one-time neonatal Fc receptor (FcRn) treatment ...
In a nation where fuel has long been both lifeblood and lightning rod, the mere whisper of ₦950 per litre stirs unease that ...
In an interview during ASH 2025, Ontada's Ira Zackson, MD explores the role of BTK inhibitors in chronic lymphocytic leukemia ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback